Search results
Testosterone and the Heart
Author(s):
Michael G Kirby
,
Geoffrey Hackett
,
Sudarshan Ramachandran
Added:
3 years ago
Article
Author(s):
Abdalla Ibrahim
,
Mohamed Ali
,
Thomas J Kiernan
,
et al
Added:
3 years ago
Erectile dysfunction (ED) is generally defined as the persistent (at least 6 months) inability to achieve and maintain penile erection sufficient to allow satisfactory sexual performance.1 It is a common condition, and recent studies predict a higher prevalence of ED in the future.2 It is estimated that ED has affected more than 150 million men worldwide and this number will reach approximately…
View more
Author(s):
Carolyn M Webb
,
Peter Collins
Added:
3 years ago
Cardiovascular disease (CVD) is the most prevalent non-communicable cause of death worldwide.1 The health and economic implications of caring for a growing ageing population with CVD is enormous. Maintaining a “healthy” elderly population that is mobile and independent with a good quality of life is vital. Testosterone is a sex hormone that is predominant in males, being secreted from the testes…
View more
Characteristics of Lipid Profile of LPL Deficiency in Japan – Comparison with Non-LPL Deficiency
Author(s):
Junji Kobayashi
Added:
3 years ago
Article
Author(s):
Robert Mentz
Added:
7 months ago
ESC 2023 — Dr Robert Mentz (Duke University Medical Center, US) joins us to provide a succinct summary of the findings and key take-home messages from the HEART-FID study (NCT03037931).
HEART-FID(American Regent, Inc.) aimed to determine the safety and efficacy of iron therapy using intravenous (IV) ferric carboxymaltose (FCM) as compared to a placebo in the treatment of patients with heart…
View more
Author(s):
S Othman Amen
,
Soza Tharwat Mohammed Baban
Added:
3 years ago
Background: Globally, coronary artery disease (CAD) and its complications, such as acute myocardial infarction (AMI), are the leading cause of morbidity and mortality. Vitamin D deficiency is a prevalent condition and it is emerging as a new risk factor for CAD. However, the correlation between vitamin deficiency and an increased risk of developing cardiovascular disease remains elusive.
Aim: To…
View more
Author(s):
Paul Kalra
Added:
10 months ago
ESC-HFA 23 – Prof Paul Kalra (Portsmouth Hospitals NHS Trust, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562).
The IRONMAN trial aimed to study the effectiveness of intravenous iron in patients with heart failure and iron deficiency when compared to standard care. It showed that administration of IV FDI led to lower rates of recurrent heart failure hospitalisations and…
View more
Cavin-2 Deficiency Attenuates Cardiac Fibrosis and Dysfunction in Pressure-overloaded Hearts
Author(s):
Yusuke Higuchi
,
Takehiro Ogata
,
Masahiro Nishi
,
et al
Added:
3 years ago
Article
Author(s):
Rachel Lampert
Added:
3 years ago
The increased risk of drug-related torsades de pointes (TdP) and death in women taking ion-channel-active antiarrhythmic drugs was first described 20 years ago. In 1993, Makkar1 identified all case reports or case series of drug-related TdP, finding 332 patients described in 83 articles. The proportion of women versus men in these reported series was compared with the proportion of women versus…
View more
Carolyn M Webb
Research Area(s) / Expertise:
Author